I guess it all depends on how much leverage the debt holders have. If the non disclosure of the Galderma contract gives them a legal way to demand early repayment and thus bankrupt the company then I would imagine the dilution will be severe. If the company doesn't have that extreme time pressure to do a deal then it might be a bit more reasonable. Unfortunately though I think the $1 days are well behind us... And although it is only a side issue I am still intrigued by the continued reference that the company is considering its response to public reports. Dunno how they could sue anyone for enough to make any difference to the bottom line and they will always have their own non-disclosure failings to deal with.
- Forums
- ASX - By Stock
- QIN
- Ann: Extension of Voluntary Suspension
Ann: Extension of Voluntary Suspension, page-31
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online